01.12.2012 Views

behavioral neurology and neuropsychiatry fellowship

behavioral neurology and neuropsychiatry fellowship

behavioral neurology and neuropsychiatry fellowship

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

42. Doody, R.S., Dunn, J.K., Clark, C., Farlow, M., Foster, N., Liao, J., Gonzales,<br />

N., Lai, E.C., Massman, P. Chronic donepezil treatment is associated with<br />

slowed cognitive decline in Alzheimer’s disease. Dementia <strong>and</strong> Geriatric<br />

Cognitive Disorders, 2001; 12: 295-300.<br />

43. Doody, R.S., Stevens, J., Beck, C., Dubinsky R., Gwyther, L., Kaye, J.,<br />

Mohs, R., Thal, L., Whitehouse, P., Dekosky, S., Cummings, J. Practice<br />

Parameter: Management of dementia (An evidence-based<br />

review)Neurology, 2001; 56(9): 1154-1166.<br />

44. Petersen, R., Doody, R., Kurz, A., Mohs, R., Morris, J., Rabins, P., Ritchie,<br />

K., Rosser, M., Thal, L. Current Concepts in Mild Cognitive Impairment.<br />

Archives of Neurology, 2001; 58:1985-1992<br />

45. Mohs, R., Doody, R.S., Morris, J., Ieni, J., Rogers, S., Perdomo, C., Pratt, R.<br />

A 1-year prospective placebo-controlled preservation of function survival<br />

study of donepezil in AD. Neurology , 2001; 57:481-488.<br />

46. Weiner M.F., Doody R.S., Sairam R., Foster B., Liao T-y. Prevalence <strong>and</strong><br />

Incidence of Major Depressive Disorder in Alzheimer’s Disease: Findings<br />

from Two Databases. Dementia <strong>and</strong> Geriatric Cognitive Disorders 2002;13:8-<br />

12<br />

47. Quinn, J., Moore, M., Benson, F., Clark, C., Doody, R., Jagust, W.,<br />

Knopman, D., Kaye, J. A videotaped CIBIC in clinical trials for dementia<br />

patients: validity <strong>and</strong> reliability in a simulated clinical trial. Neurology 2002;<br />

58:433-437<br />

48. Smith RG, Roher A, Appel S, Doody RS, Killian J, Corey-Bloom J, Sabbagh<br />

M. Autonomic sudomotor dysfunction in Alzheimer’s disease. Current<br />

Medical Chemistry – Immunology, Endocrinology <strong>and</strong> Metabolic Agents 2003;<br />

3: 233-243.<br />

49. Davis R.N., Massman, P.J., Doody, R.S. Effects of Blood Pressure on<br />

Neuropsychological Functioning in Alzheimer’s Disease. Archives of Clinical<br />

Neuropsychology, 2003; 18 (1): 19-32.<br />

50. Reisberg B, Doody R., Stoffler A., Schmitt F, Ferris S., Moebius H-J. A<br />

double-blind, placebo-controlled study of Memantine, an uncompetitive<br />

NMDA antagonist, in patients with advanced Alzheimer’s Disease. New<br />

Engl<strong>and</strong> Journal of Medicine, 2003; 348:1333-41.<br />

51. Wilkinson D, Doody R, Helme R, Taubman K, Mintzer J, Kertesz A, Pratt<br />

R.Donepezil in vascular dementia: A r<strong>and</strong>omized, placebo-controlled study.<br />

Neurology, 2003;61:479-486.<br />

UCNS Program Accreditation Application<br />

Behavioral Neurology & Neuropsychiatry February 2006<br />

Page 24

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!